VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,391,801 | -62.3% | 148,538 | -1.2% | 0.36% | -56.9% |
| Q2 2023 | $3,689,459 | +8.9% | 150,406 | +3.3% | 0.83% | +0.6% |
| Q1 2023 | $3,386,832 | +49.0% | 145,545 | +62.1% | 0.82% | +57.9% |
| Q4 2022 | $2,273,040 | +31.3% | 89,808 | 0.0% | 0.52% | +16.6% |
| Q3 2022 | $1,731,000 | -38.3% | 89,808 | -18.5% | 0.45% | -29.0% |
| Q2 2022 | $2,807,000 | +36.1% | 110,223 | +37.4% | 0.63% | +40.2% |
| Q1 2022 | $2,063,000 | +12.0% | 80,223 | +82.3% | 0.45% | +3.5% |
| Q4 2021 | $1,842,000 | – | 44,000 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |